Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication.

De LaVega AJ, Derk CT.

Expert Opin Investig Drugs. 2009 Jan;18(1):23-9. doi: 10.1517/13543780802525100 . Review.

PMID:
19053879
2.

Phosphodiesterase inhibitors in Raynaud's phenomenon.

Levien TL.

Ann Pharmacother. 2006 Jul-Aug;40(7-8):1388-93. Epub 2006 Jul 11. Review.

PMID:
16835313
3.

[Evidence-based therapy of Raynaud's syndrome].

Distler M, Distler J, Ciurea A, Kyburz D, Müller-Ladner U, Reich K, Distler O.

Z Rheumatol. 2006 Jul;65(4):285-9. Review. German.

PMID:
16804699
4.

Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease.

Caglayan E, Huntgeburth M, Karasch T, Weihrauch J, Hunzelmann N, Krieg T, Erdmann E, Rosenkranz S.

Arch Intern Med. 2006 Jan 23;166(2):231-3.

PMID:
16432094
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk